Literature DB >> 21035492

Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions.

David Gallego-Ortega1, Teresa Gómez del Pulgar, Fátima Valdés-Mora, Arancha Cebrián, Juan Carlos Lacal.   

Abstract

We have summarized here the importance of ChoKα1 in human carcinogenesis. ChoKα1 displays its oncogenic activity through activation of specific signaling pathways that influence on cell proliferation and survival. It is overexpressed in a large number of human tumors with an incidence of 40-60% of all tumors investigated. Currently, there is an active effort in the development of strategies to knockdown the activity of ChoKα through specific siRNA or small molecules inhibitors. Results from genetic silencing or from treatment with MN58b, a well characterized ChoKα inhibitor showing antiproliferative and antitumoral effect in mice xenografts, provide strong support to this concept, indicating that the design of new antitumoral drugs must be selective against this isoform. However, affecting the other two known isoforms of ChoK may have also therapeutic consequences since the physiologically active form of ChoK may be constituted by homo or heterodimers. Furthermore, alteration of the ChoKβ activity might lead to a change in the lipid content of the cells of particular tissues such as skeletal muscle as described in the ChoKβ null mice (Sher et al., 2006). Finally, the identification of the ChoKα1 isoform as an excellent novel tool for the diagnosis and prognosis of cancer patients may have clinical consequences of immediate usefulness. On one hand, the use of specific monoclonal antibodies against ChoKα1 as a tool for diagnosis in paraffin embedded samples from patient biopsies, through standard immunohistochemistry techniques, can now be achieved (Gallego-Ortega et al., 2006). On the other hand, it has been recently described the prognostic value of determination of ChoKα1 expression levels in non-small cell lung cancer using real time quantitative PCR technology (Ramírez de Molina et al., 2007). Therefore, further research should be supported on the utility of ChoK isoforms as a promising area to improve cancer diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035492     DOI: 10.1016/j.advenzreg.2010.09.010

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  21 in total

1.  Choline kinase beta is required for normal endochondral bone formation.

Authors:  Zhuo Li; Gengshu Wu; Roger B Sher; Zohreh Khavandgar; Martin Hermansson; Gregory A Cox; Michael R Doschak; Monzur Murshed; Frank Beier; Dennis E Vance
Journal:  Biochim Biophys Acta       Date:  2014-03-14

2.  Choline kinase inhibition in rheumatoid arthritis.

Authors:  M Guma; E Sanchez-Lopez; A Lodi; R Garcia-Carbonell; S Tiziani; M Karin; J C Lacal; G S Firestein
Journal:  Ann Rheum Dis       Date:  2014-10-01       Impact factor: 19.103

Review 3.  Choline metabolism-based molecular diagnosis of cancer: an update.

Authors:  Kristine Glunde; Marie-France Penet; Lu Jiang; Michael A Jacobs; Zaver M Bhujwalla
Journal:  Expert Rev Mol Diagn       Date:  2015-04-28       Impact factor: 5.225

4.  Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling.

Authors:  Amita Shukla-Dave; Mireia Castillo-Martin; Ming Chen; Jose Lobo; Nataliya Gladoun; Ana Collazo-Lorduy; Faisal M Khan; Vladimir Ponomarev; Zhengzi Yi; Weijia Zhang; Pier P Pandolfi; Hedvig Hricak; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2016-10-19       Impact factor: 4.307

Review 5.  Phosphatidylcholine and the CDP-choline cycle.

Authors:  Paolo Fagone; Suzanne Jackowski
Journal:  Biochim Biophys Acta       Date:  2012-09-23

Review 6.  Cancer metabolism: a therapeutic perspective.

Authors:  Ubaldo E Martinez-Outschoorn; Maria Peiris-Pagés; Richard G Pestell; Federica Sotgia; Michael P Lisanti
Journal:  Nat Rev Clin Oncol       Date:  2016-05-04       Impact factor: 66.675

7.  Daily rhythms of glycerophospholipid synthesis in fibroblast cultures involve differential enzyme contributions.

Authors:  Victoria A Acosta-Rodríguez; Sebastián Márquez; Gabriela A Salvador; Susana J Pasquaré; Lucas D Gorné; Eduardo Garbarino-Pico; Norma M Giusto; Mario Eduardo Guido
Journal:  J Lipid Res       Date:  2013-05-02       Impact factor: 5.922

8.  Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities.

Authors:  Rosemarie Marchan; Michaela S Lesjak; Joanna D Stewart; Roland Winter; Janine Seeliger; Jan G Hengstler
Journal:  Cell Cycle       Date:  2012-10-31       Impact factor: 4.534

Review 9.  ChoK-Full of Potential: Choline Kinase in B Cell and T Cell Malignancies.

Authors:  Samantha Gokhale; Ping Xie
Journal:  Pharmaceutics       Date:  2021-06-20       Impact factor: 6.321

10.  Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.

Authors:  Sandi A Kwee; Brenda Hernandez; Owen Chan; Linda Wong
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.